Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

Share Price is delayed by 15 minutes
Get Live Data
304.60    8.30 (2.80%)
Bid:
303.70
Ask:
303.90
Spread: 0.20 (0.066%)
Market Cap: £6.75b
SBRY Live PriceLast checked at - London Stock Exchange

Intraday Sainsbury's Share Chart

EMTN Programme Supplementary Prospectus

1 Jul 2025 12:55

RNS Number : 2446P
Sainsbury(J) PLC
01 July 2025
 

1 July 2025

 

EMTN PROGRAMME PUBLICATION OF SUPPLEMENTARY PROSPECTUS

J Sainsbury plc

(the "Company")

 

The following supplementary prospectus has been approved by the Financial Conduct Authority and is available for viewing:

 

The supplementary prospectus dated 1 July 2025 (the "Supplementary Prospectus") supplementing the base prospectus (the "Prospectus") dated 17 January 2025 relating to the establishment of the £5,000,000,000 Euro Medium Term Note Programme, with J Sainsbury plc as the issuer.

 

The Supplementary Prospectus incorporates by reference the audited financial statements of the Company for the 52-week period ended on 1 March 2025.

 

The Supplementary Prospectus should be read and construed in conjunction with the Prospectus.

 

The full document can be viewed at: http://www.rns-pdf.londonstockexchange.com/rns/2446P_1-2025-7-1.pdf

 

A copy of the Prospectus has been submitted to the Financial Conduct Authority's Electronic Submission Service and may shortly be viewed on the National Storage Mechanism (NSM) at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

J Sainsbury plc LEI Number: 213800VGZAAJIKJ9Y484

 

Enquiries

Investor Relations Media

James Collins Rebecca Reilly

 +44 (0) 7801 813 074 +44 (0) 20 7695 7295

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. The Prospectus is not intended for use in the United States and is not addressed or targeted at U.S. persons and should not be relied upon by any U.S. person. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirement. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPFFLFBEDLZBBX
Date   Source Headline
1st Feb 202410:15 amRNSTotal Voting Rights
22nd Jan 20249:15 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSStrategic review of Financial Services division
10th Jan 20247:00 amRNSTrading Statement
2nd Jan 202411:30 amRNSTotal Voting Rights
28th Dec 20234:00 pmRNSHolding(s) in Company
22nd Dec 202311:30 amRNSDirector/PDMR Shareholding
18th Dec 20232:00 pmRNSHolding(s) in Company
15th Dec 202311:55 amRNSDirector/PDMR Shareholding
1st Dec 202311:00 amRNSTotal Voting Rights
24th Nov 20231:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20234:20 pmRNSDirector Declaration
2nd Nov 20237:00 amRNSHalf-year Report
1st Nov 20231:10 pmRNSTotal Voting Rights
27th Oct 202312:15 pmRNSDirector/PDMR Shareholding
13th Oct 202312:35 pmRNSHolding(s) in Company
2nd Oct 20231:40 pmRNSTotal Voting Rights
1st Sep 20231:00 pmRNSDirector/PDMR Shareholding
1st Sep 202312:15 pmRNSTotal Voting Rights
11th Aug 20232:45 pmRNSSainsbury’s Bank sells mortgage portfolio
4th Aug 20233:45 pmRNSDirector/PDMR Shareholding
3rd Aug 20233:45 pmRNSDirector/PDMR Shareholding
1st Aug 20233:30 pmRNSBlock listing Interim Review
1st Aug 20232:30 pmRNSTotal Voting Rights
27th Jul 202312:00 pmRNSDirector/PDMR Shareholding
27th Jul 202312:00 pmRNSAdditional Listing
7th Jul 20232:35 pmRNSDirector/PDMR Shareholding
6th Jul 20232:15 pmRNSResult of AGM
4th Jul 20237:00 amRNSTrading Statement
3rd Jul 20231:45 pmRNSTotal Voting Rights
30th Jun 202312:30 pmRNSDirector Declaration
15th Jun 20231:33 pmRNSDirector/PDMR Shareholding
12th Jun 20232:50 pmRNSDirector/PDMR Shareholding
6th Jun 20233:55 pmRNSDirector/PDMR Shareholding
6th Jun 20233:40 pmRNSAnnual Report and Notice of AGM 2023
1st Jun 202312:20 pmRNSTotal Voting Rights
12th May 20233:30 pmRNSHolding(s) in Company
12th May 20231:30 pmRNSDirector/PDMR Shareholding
10th May 20233:30 pmRNSDirector/PDMR Shareholding
9th May 20234:00 pmRNSDirector/PDMR Shareholding
2nd May 20234:15 pmRNSDirector/PDMR Shareholding
2nd May 20233:45 pmRNSTotal Voting Rights
27th Apr 20237:00 amRNSFinal Results
14th Apr 20233:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:25 pmRNSTotal Voting Rights
17th Mar 20232:30 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSAcquisition of interest in investment vehicles
6th Mar 202311:00 amRNSBláthnaid Bergin becomes Chief Financial Officer
1st Mar 20231:35 pmRNSTotal Voting Rights
27th Feb 202312:10 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.